Logo image of PHAT

PHATHOM PHARMACEUTICALS INC (PHAT) Stock Earnings & Estimates

USA - Nasdaq - NASDAQ:PHAT - US71722W1071 - Common Stock

14.98 USD
-0.16 (-1.06%)
Last: 1/15/2026, 8:07:17 PM
15.14 USD
+0.16 (+1.07%)
After Hours: 1/15/2026, 8:07:17 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
PHAT revenue by date.PHAT revenue by date.
682K55.252M
8,001.47%
177.01M
220.37%
324.17M
83.14%
520.44M
60.55%
738.19M
41.84%
886.21M
20.05%
1.01B
13.97%
1.147B
13.56%
1.241B
8.20%
980.38M
-21.00%
EBITDA
YoY % growth
PHAT ebitda by date.PHAT ebitda by date.
-171.82M
-27.69%
-166.737M
2.96%
-276.672M
-65.93%
-152.689M
44.81%
33.89M
122.20%
144.27M
325.70%
380.07M
163.44%
497.43M
30.88%
606.92M
22.01%
702.66M
15.77%
781.34M
11.20%
N/A
EBIT
YoY % growth
PHAT ebit by date.PHAT ebit by date.
-172.44M
-27.66%
-167.312M
2.97%
-277.467M
-65.84%
-167.504M
39.63%
6.878M
104.11%
161.53M
2,248.50%
345.96M
114.18%
457.36M
32.20%
544.51M
19.06%
630.44M
15.78%
685.59M
8.75%
476.49M
-30.50%
Operating Margin
PHAT operating margin by date.PHAT operating margin by date.
N/A-24,532.55%-502.18%-94.63%2.12%31.04%46.87%51.61%53.91%54.96%55.24%48.60%
EPS
YoY % growth
PHAT eps by date.PHAT eps by date.
-5.05
-29.82%
-3.88
23.17%
-5.35
-37.89%
-3.25
39.18%
-0.98
69.96%
1.14
216.12%
3.58
215.11%
4.75
32.89%
5.89
23.82%
7.37
25.22%
8.23
11.70%
8.51
3.35%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth
-0.40
61.98%
-0.43
67.17%
-0.30
71.51%
-0.19
53.23%
-0.05
88.25%
-0.14
66.80%
0.08
127.27%
0.27
238.30%
0.48
1,121.74%
Revenue
Q2Q % growth
57.083M
92.43%
59.628M
109.08%
74.372M
88.27%
87.88M
77.52%
101.78M
78.30%
89.454M
50.02%
108.73M
46.20%
125.05M
42.30%
143.62M
41.11%
EBITDA
Q2Q % growth
-5.81M
90.09%
-4.619M
94.13%
3.858M
106.48%
13.405M
190.78%
16.932M
391.43%
3.876M
183.91%
15.402M
299.22%
23.154M
72.73%
31.008M
83.13%
EBIT
Q2Q % growth
-11.896M
79.98%
-12.49M
84.16%
-3.118M
94.80%
6.604M
143.25%
12.96M
208.94%
6.528M
152.27%
23.358M
849.15%
37.128M
462.20%
52.836M
307.69%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
-0.41
68.94%
-0.560.1526.25%
Q2 2025
Q2Q % growth
-1.05
32.69%
-1.060.011.02%
Q1 2025
Q2Q % growth
-1.31
7.75%
-1.17-0.14-12.00%
Q4 2024
Q2Q % growth
-1.05
24.46%
-1.300.2519.05%
Q3 2024
Q2Q % growth
-1.32
-73.68%
-1.520.2013.44%
Q2 2024
Q2Q % growth
-1.56
-85.71%
-1.41-0.15-10.83%
Q1 2024
Q2Q % growth
-1.42
-59.55%
-1.34-0.08-6.34%
Q4 2023
Q2Q % growth
-1.39
-4.51%
-1.10-0.29-26.53%
Q3 2023
Q2Q % growth
-0.76
42.42%
-0.910.1516.42%
Q2 2023
Q2Q % growth
-0.84
36.84%
-1.000.1615.84%
Q1 2023
Q2Q % growth
-0.89
16.82%
-1.290.4030.78%
Q4 2022
Q2Q % growth
-1.33
-40.00%
-1.380.053.53%
Q3 2022
Q2Q % growth
-1.32
-34.69%
-1.340.021.79%
Q2 2022
Q2Q % growth
-1.33
-33.00%
-1.05-0.28-26.59%
Q1 2022
Q2Q % growth
-1.07
-11.46%
-0.99-0.08-8.37%
Q4 2021
Q2Q % growth
-0.95
39.87%
-1.050.109.43%
Q3 2021
Q2Q % growth
-0.98
3.92%
-1.000.021.96%
Q2 2021
Q2Q % growth
-1.00
-56.25%
-1.090.098.23%
Q1 2021
Q2Q % growth
-0.96
-54.84%
-1.210.2520.80%
Q4 2020
Q2Q % growth
-1.58 -1.03-0.55-53.12%
Q3 2020
Q2Q % growth
-1.02 -0.69-0.33-48.52%
Q2 2020
Q2Q % growth
-0.64 -0.57-0.07-12.04%
Q1 2020
Q2Q % growth
-0.62 -0.730.1115.19%
PHAT Yearly EPS VS EstimatesPHAT Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 5 -5 -10
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
49.504M
202.74%
47.933M1.571M3.28%
Q2 2025
Q2Q % growth
39.503M
439.36%
36.798M2.705M7.35%
Q1 2025
Q2Q % growth
28.519M
1,391.58%
29.596M-1.077M-3.64%
Q4 2024
Q2Q % growth
29.664M
4,249.56%
25.408M4.256M16.75%
Q3 2024
Q2Q % growth
16.352M 12.861M3.491M27.14%
Q2 2024
Q2Q % growth
7.324M 5.925M1.399M23.61%
Q1 2024
Q2Q % growth
1.912M 2.088M-176K-8.43%
Q4 2023
Q2Q % growth
682K 420.577K261.423K62.16%
Q3 2022
Q2Q % growth
204K-204K-100.00%
Q1 2022
Q2Q % growth
215.22K-215.22K-100.00%
PHAT Yearly Revenue VS EstimatesPHAT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 200M 400M 600M 800M 1B
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-0.37% -3.92% 0.13% 1.75%
Revenue0.21% 0.77% 0.56% 2.32%